本页面由Tiger Trade Technology Pte. Ltd.提供服务

GE HEALTHCARE TECHNOLOGIES INC

67.74
+2.003.04%
盘后:67.940.2000+0.30%19:59 EDT
成交量:375.24万
成交额:2.54亿
市值:305.97亿
市盈率:15.61
高:68.34
开:66.02
低:65.74
收:65.74
52周最高:89.77
52周最低:58.75
股本:4.52亿
流通股本:4.52亿
量比:0.95
换手率:0.83%
股息:0.14
股息率:0.21%
每股收益(TTM):4.34
每股收益(LYR):4.55
净资产收益率:19.38%
总资产收益率:5.13%
市净率:2.79
市盈率(LYR):14.89

数据加载中...

2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/22

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/12

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report